Skip to main content
. 2021 Feb 11;12:630831. doi: 10.3389/fphys.2021.630831

TABLE 1.

Changes in cardiometabolic health outcomes after 12-week intervention among control and concurrent training group.

Control group (n = 6) Concurrent training group (n = 6) Net effect



Baseline Mean (SD) After 12 weeks Mean (SD) Δ (SE) Baseline Mean (SD) After 12 weeks Mean (SD) Δ (SE) Mean difference (95% CI) Standardized mean difference (95% CI)
Age (years) 43.7 (6.1) 41.3 (4.4)
Anthropometry and body composition
Weight (kg) 101.4 (12.9) 103.5 (14.4) 2.13 (0.88) 97.5 (15.4) 95.4 (12.9) −2.08(1.33) 4.21(0.45,8.37) 1.23(0.01,2.45)*
Body mass index (kg/m2) 32.5 (3.0) 33.2 (3.3) 0.65 (0.26) 32.1 (3.6) 31.4 (2.7) −0.67(0.42) 1.32(0.01,2.63) 1.23(0.01,2.45)*
Waist circumference (cm) 108.0 (6.1) 107.9 (8.0) −0.05(1.52) 105.4 (9.4) 104.1 (8.3) −1.23(0.98) 1.18(−2.79,5.15) 0.46(−1.08,1.99)
Fat mass (kg) 28.5 (7.3) 30.7 (7.6) 2.15 (0.70) 27.8 (6.6) 26.6 (4.8) −1.12(0.83) 3.27(0.56,5.97) 1.36(0.23,2.48)*
Lean mass (kg) 69.3 (6.9) 69.3 (7.4) 0.00 (0.71) 66.3 (9.3) 65.3 (8.4) −0.93(0.51) 0.93(−0.69,2.56) 0.82(−0.61,2.25)
Bone mineral content (kg) 3.60 (0.32) 3.58 (0.36) −0.03(0.03) 3.43 (0.46) 3.40 (0.41) −0.03(0.33) 0.01(−0.98,0.11) 0.12(−1.45,1.70)
Blood pressure
Systolic blood pressure (mm Hg) 131.5 (16.9) 130.0 (18.6) −1.50(1.21) 131.4 (22.0) 120.2 (14.8) −11.22(3.63) 9.72(0.38,19.07) 1.15(0.04,2.26)*
Diastolic blood pressure (mm Hg) 83.2 (6.3) 86.9 (8.1) 3.75 (1.80) 86.6 (13.9) 79.0 (8.8) −7.61(3.40) 11.36(1.02,21.70) 1.29(0.12,2.47)*
Mean blood pressure (mm Hg) 99.3 (9.2) 101.3 (11.4) 2.00 (1.58) 101.5 (16.5) 92.7 (10.4) −8.81(3.45) 10.81(1.79,19.84) 1.26(0.21,2.30)*
Glycemic profile
Plasma glucose (mg/dL) 101.5 (3.9) 100.3 (3.8) −1.25(2.21) 94.8 (9.1) 93.8 (8.5) −1.00(1.52) −0.25(−6.39,5.89) −0.07(−1.76,1.63)
Plasma insulin (UI/mL) 13.9 (4.2) 19.6 (11.1) 5.71 (4.00) 8.6 (2.0) 8.3 (3.8) −0.26(2.38) 5.97(−4.50,16.44) 0.86(−0.65,2.37)
HOMA-IR 3.47 (1.02) 4.84 (2.75) 1.37 (1.05) 2.00 (0.52) 1.96 (0.98) −0.04(0.55) 1.42(−1.22,4.05) 0.82(−0.71,2.35)
Lipid profile
Total cholesterol (mg/dL) 216.0 (59.8) 212.5 (47.2) −3.50(15.09) 198.0 (22.6) 211.8 (42.5) 13.80 (13.4) −17.30(−65.02,30.42) 0.58(−2.19,1.03)
HDL-C (mg/dL) 48.8 (9.6) 46.8 (1.7) −2.00(5.35) 40.8 (5.0) 43.8 (4.9) 3.00 (0.45) −5.00(−16.18,6.18) −0.70(−2.28,0.87)
LDL-C (mg/dL) 145.0 (50.3) 142.3 (41.5) −2.75(9.29) 130.8 (22.0) 147.6 (37.7) 16.80 (9.07) −19.55(−50.60,11.50) −0.93(−2.41,0.55)
Triglycerides (mg/dL) 112.0 (53.9) 118.5 (44.6) 6.50 (16.98) 131.4 (70.5) 102.0 (56.5) −29.40(30.55) 35.90(−53.28,125.08) 0.64(−0.95,2.24)
Liver function
GOT (IU/L) 29.3 (8.5) 33.0 (2.8) 3.75 (2.93) 21.6 (8.1) 21.2 (7.6) −0.40(0.68) 4.15(−2.19,10.49) 0.96(−0.51,2.42)
GPT (IU/L) 44.0 (27.5) 46.5 (21.6) 2.50 (3.12) 22.0 (7.2) 23.8 (13.4) 1.80 (3.76) 0.70(−11.29,12.69) 0.10(−1.59,1.79)
γ-GT (IU/L) 68.5 (75.2) 73.3 (62.7) 4.75 (11.28) 27.2 (8.23) 27.2 (13.3) 0.00 (3.56) 4.75(−20.55,30.05) 0.31(−1.36,1.99)
Fatty liver index 90.8 (6.9) 93.6 (5.0) 2.77 (8.40) 67.9 (62.2) 62.2 (16.5) −5.64(7.39) 8.42(−25.51,42.34) 0.63(−1.91,3.17)
Cardiovascular risk Z-Score 0.023 (0.525) 0.203 (0.416) 0.180 (0.089) 0.084 (0.506) −0.136(0.358) −0.220(0.148) 0.39(0.04,0.83) 1.30(0.12,2.51)*
Other biochemical parameters
Protein C reactive (mg/dL) 11.7 (18.1) 8.2 (9.4) −3.53(4.47) 1.6 (0.8) 1.8 (1.0) 0.18 (0.17) −3.71(−13.01,5.60) −0.64(−2.23,0.96)
Leptin (ng/mL) 19.8 (5.1) 21.0 (6.4) 1.18 (1.00) 23.3 (12.1) 15.7 (3.0) −7.58(5.03) 8.76(−4.89,22.40) 0.94(−0.52,2.41)
Energy metabolism
RMR (kcal/kg/day) 18.78 (1.00) 20.24 (1.75) 1.46 (1.72) 20.13 (2.53) 20.55 (1.77) 0.41 (1.98) −1.09(−2.02,4.19) 0.57(−0.59,1.72)
RQ 0.867 (0.172) 0.861 (0.173) −0.006(0.021) 0.831 (0.194) 0.824 (0.188) −0.007(0.028) −0.001(−0.018,0.014) −0.04(−1.17,1.09)
RFox (g/min) 0.084 (0.026) 0.102 (0.044) 0.018 (0.014) 0.081 (0.027) 0.082 (0.023) 0.001 (0.008) 0.02(−0.02,0.05) 0.71(−0.76,2.18)
RFox (% RMR) 50.8 (19.3) 60.6 (25.8) 9.76 (11.95) 51.5 (16.6) 50.7 (12.5) −0.75(4.92) 10.50(−25.27,46.26) 0.61(−1.46,2.67)
RCHox (g/min) 0.148 (0.065) 0.131 (0.086) −0.017(0.045) 0.154 (0.049) 0.153 (0.035) −0.001(0.017) −0.02(−0.15,0.12) −0.27(−2.48,1.95)
RCHox (% RMR) 46.4 (17.3) 38.8 (25.4) −7.66(10.98) 49.1 (17.2) 48.0 (12.5) −1.12(4.95) −6.53(−39.24,26.18) −0.41(−2.46,1.64)
MFO (g/min) 0.24 (0.03) 0.26 (0.07) 0.019 (0.037) 0.24 (0.05) 0.25 (0.03) 0.010 (0.020) 0.01(−0.08,0.10) 0.17(−1.39,1.75)
Fatmax (% VO2max) 48.8 (9.5) 54.6 (6.9) 5.85 (3.91) 51.5 (6.8) 53.1 (7.3) 1.58 (3.75) 4.28(−8.67,17.24) 0.50(−1.02,2.03)
Dietary intake
Energy intake (kcal/day) 2868 (972) 2796 (680) −71.5(370.9) 2911 (518) 2436 (408) −474.7(272.7) 403.2(−633.6,1439.9) 0.59(−0.91,2.09)
Carbohydrate intake (g/day) 281.0 (81.1) 277.8 (121.7) −3.25(47.53) 238.3 (47.9) 284.0 (42.6) 45.67 (30.27) 48.92(−74.04,171.88) 0.60(−0.90,2.10)
Sugar intake (g/day) 114.6 (32.6) 84.7 (22.4) −29.83(21.31) 111.1 (20.0) 91.5 (19.1) −19.63(8.91) −10.19(−73.91,53.53) −0.34(−2.47,1.79)
Far intake (g/day) 103.3 (56.1) 116.2 (37.6) 2.93 (25.34) 126.7 (23.8) 104.3 (26.7) −22.35(15.95) 25.28(−39.91,90.46) 0.58(−0.92,2.09)
Protein intake (g/day) 130.2 (39.4) 121.6 (38.4) −8.55(14.33) 110.5 (23.4) 107.5 (15.2) −2.97(8.96) −5.58(−48.26,37.09) −0.24(−1.80,1.33)
Alcohol intake (g/day) 13.4 (11.6) 14.1 (13.5) −0.70(6.02) 19.3 (23.8) 10.9 (7.6) −8.40(10.13) 9.10(−22.11,40.31) 0.45(−1.09,1.98)
Physical activity and sedentary behavior
Sedentary time (min/day) 7122.5 (1694.2) 6834.3 (1018.9) −288.25(754.93) 7323.4 (478.5) 7291.2 (855.9) −32.20(205.50) −256.1(−1917.9,1405.8) −0.26(−1.94,1.42)
LPA (min/day) 9807.0 (268.9) 9782.5 (89.2) −24.50(147.99) 9864.8 (118.6) 9833.4 (47.3) −31.40(66.08) 6.90(−347.87,361.67) 0.03(−1.66,1.73)
MPA (min/day) 272.8 (268.9) 296.3 (88.8) 23.50 (147.81) 188.8 (92.9) 239.4 (43.6) 50.60 (45.83) −27.10(−357.76,303.56) −0.14(−1.83,1.55)
VPA (min/day) 0.3 (0.5) 0.3 (0.5) 0.00 (0.41) 3.4 (3.1) 25.8 (57.1) 22.40 (25.94) 22.40(−47.16,91.96) 0.52(−1.10,2.15)
MVPA (min/day) 273.0 (268.9) 296.5 (89.2) 23.50 (147.99) 215.2 (118.6) 145.6 (47.27) 30.40 (66.08) −6.90(−361.67,347.87) −0.03(−1.73,1.66)
Cardiorespiratory fitness
VO2max (mL/min) 2596.3 (472.2) 2876.0 (524.4) 279.75 (95.79) 2620.3 (573.3) 2913.5 (561.4) 293.17 (299.34) −13.42(−893.75,866.92) −0.24(−1.60,1.55)
VO2max (mL/kg/min) 25.6 (2.3) 27.7 (2.6) 2.19 (0.88) 27.4 (7.4) 30.7 (5.5) 3.31 (2.97) −1.11(−8.74,6.51) −0.20(−1.57,1.17)
Echocardiography
Cardiac mass (g) 207.4 (32.0) 181.8 (42.3) −25.57(7.08) 192.6 (27.8) 197.5 (21.9) 4.88 (15.3) −30.45(−72.41,11.51) −1.01(−2.39,0.38)
Ejection fraction (%) 65.8 (6.2) 61.0 (1.8) −4.75(2.69) 66.2 (5.7) 61.6 (7.4) −4.60(3.87) −0.15(−11.93,11.63) −0.02(−1.72,1.67)
LV end diastolic diameter (mm) 52.5 (5.2) 50.8 (3.5) −1.75(1.25) 52.6 (3.2) 55.2 (0.4) 2.60 (1.54) −4.35(−9.22,−0.52) −1.28(−2.50,−0.14)*
LV end systolic diameter (mm) 26.3 (4.0) 30.5 (2.6) 4.25 (1.89) 33.4 (3.6) 34.2 (3.7) 0.80 (0.80) 3.45(−2.20,9.10) 1.08(0.69,2.84)
LV end systolic volume (mL) 21.5 (10.3) 28.0 (15.3) 6.50 (5.33) 22.4 (2.4) 34.6 (10.6) 12.20 (4.62) −5.70(−22.31,10.91) −0.56(−2.18,1.06)
E wave (cm/s) 87.3 (12.5) 81.8 (23.7) −5.50(8.93) 70.2 (20.8) 67.6 (16.3) −2.60(6.17) −2.90(−27.75,21.95) −0.20(−1.88,1.49)
A wave (cm/s) 55.8 (3.7) 59.8 (2.6) 4.00 (3.16) 65.8 (17.4) 61.8 (8.4) −4.00(8.61) 8.00(−15.51,31.51) −0.55(−1.08,2.18)
E/A 1.57 (0.26) 1.37 (0.38) −0.20(0.08) 1.07 (0.13) 1.10 (0.26) 0.04 (0.16) 0.24(−0.69,0.21) 0.81(−2.34,0.71)
E wave deceleration time (ms) 205.0 (20.4) 212.5 (24.7) 7.50 (21.26) 261.0 (43.8) 223.0 (31.3) −38.00(25.62) 45.50(−36.17,127.17) 0.85(−0.67,2.36)

Abbreviations: SD, standard deviation; SE, standard error; CI; confidence interval; HOMA, homeostasis model assessment; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; GOT, Glutamic oxaloacetic transaminase; GPT, glutamic-pyruvic transaminase; γ-GT, γ-glutamyl transferase; RMR, resting metabolic rate; RFox, resting fat oxidation; RCHox, resting carbohydrate oxidation; MFO, maximal fat oxidation during exercise; Fatmax, intensity that elicits MFO; LPA, physical activity levels at light intensity; MPA, physical activity levels at moderate intensity; VPA, physical activity levels at vigorous intensity; MVPA, physical activity levels at moderate-vigorous intensity; VO2max, maximal oxygen uptake; LV, left ventricle. Analyses were performed using multilevel mixed analysis including group as a fixed variable (control group vs. exercise).

*Significant differences between groups (P < 0.05).